Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger.

Ibrahim ML, Steenkeste N, Khim N, Adam HH, Konaté L, Coppée JY, Ariey F, Duchemin JB.

Malar J. 2009 Feb 23;8:32. doi: 10.1186/1475-2875-8-32.

2.

[The current status of the resistance of malaria pathogens to antimalarials].

Kondrashin AV, Baranova AM, Morozov EN, Morozova LF, Stepanova EV.

Med Parazitol (Mosk). 2014 Jul-Sep;(3):51-7. Review. Russian.

PMID:
25286554
3.

Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic review.

Mvumbi DM, Kayembe JM, Situakibanza H, Bobanga TL, Nsibu CN, Mvumbi GL, Melin P, De Mol P, Hayette MP.

Malar J. 2015 Sep 17;14:354. doi: 10.1186/s12936-015-0892-z. Review.

4.

Genetic and genomic approaches for the discovery of parasite genes involved in antimalarial drug resistance.

Mwangi JM, Ranford-Cartwright LC.

Parasitology. 2013 Oct;140(12):1455-67. doi: 10.1017/S0031182013000954. Epub 2013 Aug 9. Review.

PMID:
23931581
5.

Challenges of drug-resistant malaria.

Sinha S, Medhi B, Sehgal R.

Parasite. 2014;21:61. doi: 10.1051/parasite/2014059. Epub 2014 Nov 18. Review.

6.

A better resolution for integrating methods for monitoring Plasmodium falciparum resistance to antimalarial drugs.

Abdul-Ghani R, Al-Maktari MT, Al-Shibani LA, Allam AF.

Acta Trop. 2014 Sep;137:44-57. doi: 10.1016/j.actatropica.2014.04.031. Epub 2014 May 4. Review.

PMID:
24801884
7.

Malaria, anti malarial drugs and the role of melatonin.

Srinivasan V, Mohamed M, Zakaria R, Ahmad AH.

Infect Disord Drug Targets. 2012 Oct;12(5):371-9. Review.

PMID:
23082960
8.

Drug resistance and genetic mapping in Plasmodium falciparum.

Hayton K, Su XZ.

Curr Genet. 2008 Nov;54(5):223-39. doi: 10.1007/s00294-008-0214-x. Epub 2008 Sep 18. Review.

PMID:
18802698
9.

Plasmodium falciparum: epigenetic control of var gene regulation and disease.

Deshmukh AS, Srivastava S, Dhar SK.

Subcell Biochem. 2013;61:659-82. doi: 10.1007/978-94-007-4525-4_28. Review.

PMID:
23150271
10.

Emerging importance of mismatch repair components including UvrD helicase and their cross-talk with the development of drug resistance in malaria parasite.

Ahmad M, Tuteja R.

Mutat Res. 2014 Dec;770:54-60. doi: 10.1016/j.mrfmmm.2014.09.009. Epub 2014 Sep 28. Review.

PMID:
25771870
11.

DNA repair mechanisms and their biological roles in the malaria parasite Plasmodium falciparum.

Lee AH, Symington LS, Fidock DA.

Microbiol Mol Biol Rev. 2014 Sep;78(3):469-86. doi: 10.1128/MMBR.00059-13. Review.

12.

Antimalarial drug targets and drugs targeting dolichol metabolic pathway of Plasmodium falciparum.

Qidwai T, Priya A, Khan NA, Tripathi H, Khan F, Darokar MP, Pal A, Bawankule DU, Shukla RK, Bhakuni RS.

Curr Drug Targets. 2014 Apr;15(4):374-409. Review.

PMID:
23848395
13.

Using genetic methods to define the targets of compounds with antimalarial activity.

Flannery EL, Fidock DA, Winzeler EA.

J Med Chem. 2013 Oct 24;56(20):7761-71. doi: 10.1021/jm400325j. Epub 2013 Sep 6. Review.

14.

Global phenotypic screening for antimalarials.

Guiguemde WA, Shelat AA, Garcia-Bustos JF, Diagana TT, Gamo FJ, Guy RK.

Chem Biol. 2012 Jan 27;19(1):116-29. doi: 10.1016/j.chembiol.2012.01.004. Review.

15.

Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.

Hughes D, Andersson DI.

Nat Rev Genet. 2015 Aug;16(8):459-71. doi: 10.1038/nrg3922. Epub 2015 Jul 7. Review.

PMID:
26149714
Items per page

Supplemental Content

Write to the Help Desk